SCHEMBL13367495

SCHEMBL13367495

CN(c1ccc(-c2ccccc2)cc1)c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
CHRM2 P08172 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
DRD1 P21728 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
HRH1 P35367 1/20 0.41
OPRK1 P41145 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4805106 0.88 CYP2D6 (0.50) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
Hydrochloric Acid SCHEMBL4509968 0.86 CYP2D6 (0.48) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
Hydrochloric Acid SCHEMBL2085181 0.86 CYP2D6 (0.48) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL23079715 0.84 CYP2D6 (0.41) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL13367387 0.83 ALDH1A1 (0.50) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL17602105 0.81 GRIA1 (0.52) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL29912449 0.81 CYP2D6 (0.44) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL13338158 0.81 CYP2D6 (0.44) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL5206210 0.81 CYP2D6 (0.44) CYP2D6CYP2C19CHRM2ADRA2AADRA2B
SCHEMBL28358475 0.81 CYP2D6 (0.51) CYP2D6CYP2C19CHRM2ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 CYP2D6 1421/4885CYP2C19 1808/4885CHRM2 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.